Literature DB >> 16921105

Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters.

Victor Pinto-Plata1, John Toso, Kwan Lee, John Bilello, Hana Mullerova, Mary De Souza, Rupert Vessey, Bartolome Celli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16921105     DOI： 10.1513/pats.200603-030MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN： 1546-3222


× No keyword cloud information.
  8 in total

1.  The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema.

Authors:  Jeffrey J Atkinson; Barbara A Lutey; Yoko Suzuki; Holly M Toennies; Diane G Kelley; Dale K Kobayashi; Whitney G Ijem; Gaetan Deslee; Carla H Moore; M Eileen Jacobs; Susan H Conradi; David S Gierada; Richard A Pierce; Tomoko Betsuyaku; Robert M Senior
Journal:  Am J Respir Crit Care Med       Date:  2010-11-05       Impact factor: 21.405

2.  Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease.

Authors:  Benjamin L Nicholas; Paul Skipp; Sheila Barton; Dave Singh; Dinesh Bagmane; Richard Mould; Gilbert Angco; Jon Ward; Binita Guha-Niyogi; Susan Wilson; Peter Howarth; Donna E Davies; Stephen Rennard; C David O'Connor; Ratko Djukanovic
Journal:  Am J Respir Crit Care Med       Date:  2010-01-28       Impact factor: 21.405

3.  Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

Authors:  Alvar Agustí; Lisa D Edwards; Stephen I Rennard; William MacNee; Ruth Tal-Singer; Bruce E Miller; Jørgen Vestbo; David A Lomas; Peter M A Calverley; Emiel Wouters; Courtney Crim; Julie C Yates; Edwin K Silverman; Harvey O Coxson; Per Bakke; Ruth J Mayer; Bartolome Celli
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

4.  Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?

Authors:  Alfonso Carleo; Joanna Chorostowska-Wynimko; Thomas Koeck; Harald Mischak; Małgorzata Czajkowska-Malinowska; Adriana Rozy; Tobias Welte; Sabina Janciauskiene
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-08

5.  Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.

Authors:  Bartolome R Celli; Julie A Anderson; Robert Brook; Peter Calverley; Nicholas J Cowans; Courtney Crim; Ian Dixon; Victor Kim; Fernando J Martinez; Andrea Morris; David E Newby; Julie Yates; Joergen Vestbo
Journal:  BMJ Open Respir Res       Date:  2019-05-04

6.  Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage.

Authors:  Maria Dolores Pastor; Ana Nogal; Sonia Molina-Pinelo; Ricardo Meléndez; Beatriz Romero-Romero; Maria Dolores Mediano; Jose L López-Campos; Rocío García-Carbonero; Amparo Sanchez-Gastaldo; Amancio Carnero; Luis Paz-Ares
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

Review 7.  Application of proteomics and peptidomics to COPD.

Authors:  Girolamo Pelaia; Rosa Terracciano; Alessandro Vatrella; Luca Gallelli; Maria Teresa Busceti; Cecilia Calabrese; Cristiana Stellato; Rocco Savino; Rosario Maselli
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

8.  Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers.

Authors:  Qiuying Chen; Ruba S Deeb; Yuliang Ma; Michelle R Staudt; Ronald G Crystal; Steven S Gross
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.